Technology
Health
Medical

Insulet

$103.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.30 (-2.17%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Insulet and other stocks, options, ETFs, and crypto commission-free!

About

Insulet Corporation Common Stock, also called Insulet, is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. Read More The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Employees
1,169
Headquarters
Acton, Massachusetts
Founded
2000
Market Cap
6.20B
Price-Earnings Ratio
447.76
Dividend Yield
0.00
Average Volume
681.33K
High Today
$107.60
Low Today
$103.30
Open Price
$105.47
Volume
179.28K
52 Week High
$108.91
52 Week Low
$70.80

Collections

Technology
Health
Medical
Advertising and Marketing
Business Services
US
North America
Female CEOs

News

Yahoo FinanceMay 15

Insulet and West Pharma Proven Winners in Growing Wearable Devices Market

- By Barry Cohen With rapid growth projected for the market for wearable drug delivery devices, investors would be wise to consider some of the key players in the business. Two standouts are Boston-area-based Insulet (PODD) and West Pharmaceutical Services (WST), which is headquartered in Exton, Pennsylvania. These companies don't make the drugs. They develop the devices patients wear that deliver the medications. Both firms have rewarded shareholders handsomely. Insulet, which is worth more than...

30
Yahoo FinanceMay 13

Insulet and Novocure Are Going Gangbusters

Insulet (NASDAQ: PODD) and Novocure (NASDAQ: NVCR) both recently knocked the cover off of the ball in their recent earnings reports.

60
NasdaqMay 6

Health Care Sector Update for 05/06/2019: PODD,BHC,BHC.TO,ESPR,HMSY

31

Earnings

-$0.19
-$0.07
$0.04
$0.16
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.